{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:25:42Z","timestamp":1790641542363,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PFIS FI12\/00457"],"award-info":[{"award-number":["PFIS FI12\/00457"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI14\/01115"],"award-info":[{"award-number":["FIS PI14\/01115"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI17\/00134"],"award-info":[{"award-number":["FIS PI17\/00134"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI13\/00584"],"award-info":[{"award-number":["FIS PI13\/00584"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI14\/00328"],"award-info":[{"award-number":["FIS PI14\/00328"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI11\/01043"],"award-info":[{"award-number":["FIS PI11\/01043"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI14\/00410"],"award-info":[{"award-number":["FIS PI14\/00410"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP11\/00080"],"award-info":[{"award-number":["CP11\/00080"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CPII16\/00016"],"award-info":[{"award-number":["CPII16\/00016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI15\/00857"],"award-info":[{"award-number":["FIS PI15\/00857"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MINECO|Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI17\/00916"],"award-info":[{"award-number":["FIS PI17\/00916"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Government of Catalonia|Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["SGR 2017SGR1206"],"award-info":[{"award-number":["SGR 2017SGR1206"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Government of Catalonia|Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["SGR 2017SGR696"],"award-info":[{"award-number":["SGR 2017SGR696"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Government of Catalonia|Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["SGR 2014SGR1430"],"award-info":[{"award-number":["SGR 2014SGR1430"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"EC|Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\u2010241622"],"award-info":[{"award-number":["FP7\u2010241622"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Leukodystrophies Association","award":["ELA2012\u2010033C1"],"award-info":[{"award-number":["ELA2012\u2010033C1"]}]},{"name":"Centre for Biomedical Research on Rare Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.15252\/emmm.201708604","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T05:36:15Z","timestamp":1531287375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Aberrant regulation of the GSK\u20103\u03b2\/NRF2 axis unveils a novel therapy for adrenoleukodystrophy"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6478-3815","authenticated-orcid":false,"given":"Pablo","family":"Ranea\u2010Robles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel Ylagan","family":"Calingasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Naud\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Portero\u2010Ot\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinald","family":"Pamplona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidre","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Flint","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8031-5007","authenticated-orcid":false,"given":"St\u00e9phane","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9606-0600","authenticated-orcid":false,"given":"Aurora","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"BFEMMM201708604_CR1","first-page":"Unit 12.11","volume":"Chapter 12","author":"SM Abmayr","year":"2006","unstructured":"Abmayr SM, Yao T, Parmely T, Workman JL (2006) Preparation of nuclear and cytoplasmic extracts from mammalian cells. Curr Protoc Mol Biol Chapter 12: Unit 12.11","journal-title":"Curr Protoc Mol Biol"},{"key":"BFEMMM201708604_CR2","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1523\/JNEUROSCI.0426-16.2016","volume":"36","author":"M Ahuja","year":"2016","unstructured":"Ahuja M, Ammal Kaidery N, Yang L, Calingasan N, Smirnova N, Gaisin A, Gaisina IN, Gazaryan I, Hushpulian DM, Kaddour\u2010Djebbar I et\u00a0al (2016) Distinct Nrf2 signaling mechanisms of fumaric acid esters and their role\u00a0in neuroprotection against 1\u2010Methyl\u20104\u2010Phenyl\u20101,2,3,6\u2010tetrahydropyridine\u2010induced experimental parkinson's\u2010like disease. J Neurosci 36: 6332\u20136351","journal-title":"J Neurosci"},{"key":"BFEMMM201708604_CR3","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.bbadis.2017.06.003","volume":"1863","author":"MC van de Beek","year":"2017","unstructured":"van de Beek MC, Ofman R, Dijkstra I, Wijburg F, Engelen M, Wanders R, Kemp S (2017) Lipid\u2010induced endoplasmic reticulum stress in X\u2010linked adrenoleukodystrophy. Biochim Biophys Acta 1863: 2255\u20132265","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM201708604_CR4","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1006\/bbrc.1994.2855","volume":"205","author":"J Berger","year":"1994","unstructured":"Berger J, Molzer B, Fae I, Bernheimer H (1994) X\u2010linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem Biophys Res Commun 205: 1638\u20131643","journal-title":"Biochem Biophys Res Commun"},{"key":"BFEMMM201708604_CR5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/21678421.2013.839708","volume":"15","author":"P Bergstrom","year":"2014","unstructured":"Bergstrom P, von Otter M, Nilsson S, Nilsson AC, Nilsson M, Andersen PM, Hammarsten O, Zetterberg H (2014) Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 15: 130\u2013137","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"BFEMMM201708604_CR6","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.1203057","volume":"190","author":"E Beurel","year":"2013","unstructured":"Beurel E, Kaidanovich\u2010Beilin O, Yeh WI, Song L, Palomo V, Michalek SM, Woodgett JR, Harrington LE, Eldar\u2010Finkelman H, Martinez A et\u00a0al (2013) Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase\u20103. J Immunol 190: 5000\u20135011","journal-title":"J Immunol"},{"key":"BFEMMM201708604_CR7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1089\/ars.2015.6622","volume":"24","author":"MS Brennan","year":"2016","unstructured":"Brennan MS, Patel H, Allaire N, Thai A, Cullen P, Ryan S, Lukashev M, Bista P, Huang R, Rhodes KJ et\u00a0al (2016) Pharmacodynamics of dimethyl fumarate are tissue specific and involve NRF2\u2010dependent and \u2010independent mechanisms. Antioxid Redox Signal 24: 1058\u20131071","journal-title":"Antioxid Redox Signal"},{"key":"BFEMMM201708604_CR8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuro.2006.07.019","volume":"27","author":"NC Burton","year":"2006","unstructured":"Burton NC, Kensler TW, Guilarte TR (2006) In vivo modulation of the Parkinsonian phenotype by Nrf2. Neurotoxicology 27: 1094\u20131100","journal-title":"Neurotoxicology"},{"key":"BFEMMM201708604_CR9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1073\/pnas.0408487101","volume":"102","author":"MJ Calkins","year":"2005","unstructured":"Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA (2005) Protection from mitochondrial complex II inhibition in\u00a0vitro and in\u00a0vivo by Nrf2\u2010mediated transcription. Proc Natl Acad Sci USA 102: 244\u2013249","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201708604_CR10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier N, Hacein\u2010Bey\u2010Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, Vidaud M, Abel U, Dal\u2010Cortivo L, Caccavelli L et\u00a0al (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X\u2010linked adrenoleukodystrophy. Science 326: 818\u2013823","journal-title":"Science"},{"key":"BFEMMM201708604_CR11","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","volume":"106","author":"PC Chen","year":"2009","unstructured":"Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA (2009) Nrf2\u2010mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc Natl Acad Sci USA 106: 2933\u20132938","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201708604_CR12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","volume":"7","author":"MP Coghlan","year":"2000","unstructured":"Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L et\u00a0al (2000) Selective small molecule inhibitors of glycogen synthase kinase\u20103 modulate glycogen metabolism and gene transcription. Chem Biol 7: 793\u2013803","journal-title":"Chem Biol"},{"key":"BFEMMM201708604_CR13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/cdd.2014.179","volume":"22","author":"JJ Credle","year":"2015","unstructured":"Credle JJ, George JL, Wills J, Duka V, Shah K, Lee YC, Rodriguez O, Simkins T, Winter M, Moechars D et\u00a0al (2015) GSK\u20103beta dysregulation contributes to parkinson's\u2010like pathophysiology with associated region\u2010specific phosphorylation and accumulation of tau and alpha\u2010synuclein. Cell Death Differ 22: 838\u2013851","journal-title":"Cell Death Differ"},{"key":"BFEMMM201708604_CR14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.abb.2010.03.019","volume":"501","author":"AT Dinkova\u2010Kostova","year":"2010","unstructured":"Dinkova\u2010Kostova AT, Talalay P (2010) NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys 501: 116\u2013123","journal-title":"Arch Biochem Biophys"},{"key":"BFEMMM201708604_CR15","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1096\/fj.08-120410","volume":"23","author":"T Duka","year":"2009","unstructured":"Duka T, Duka V, Joyce JN, Sidhu A (2009) Alpha\u2010Synuclein contributes to GSK\u20103beta\u2010catalyzed Tau phosphorylation in Parkinson's disease models. FASEB J 23: 2820\u20132830","journal-title":"FASEB J"},{"key":"BFEMMM201708604_CR16","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","volume":"377","author":"F Eichler","year":"2017","unstructured":"Eichler F, Duncan C, Musolino PL, Orchard PJ, De Oliveira S, Thrasher AJ, Armant M, Dansereau C, Lund TC, Miller WP et\u00a0al (2017) Hematopoietic stem\u2010cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med 377: 1630\u20131638","journal-title":"N Engl J Med"},{"key":"BFEMMM201708604_CR17","doi-asserted-by":"crossref","first-page":"e16172","DOI":"10.1371\/journal.pone.0016172","volume":"6","author":"G Ellrichmann","year":"2011","unstructured":"Ellrichmann G, Petrasch\u2010Parwez E, Lee DH, Reick C, Arning L, Saft C, Gold R, Linker RA (2011) Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of Huntington's disease. PLoS One 6: e16172","journal-title":"PLoS One"},{"key":"BFEMMM201708604_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","volume":"7","author":"M Engelen","year":"2012","unstructured":"Engelen M, Kemp S, de Visser M, van Geel BM, Wanders RJ, Aubourg P, Poll\u2010The BT (2012) X\u2010linked adrenoleukodystrophy (X\u2010ALD): clinical presentation and guidelines for diagnosis, follow\u2010up and management. Orphanet J Rare Dis 7: 51","journal-title":"Orphanet J Rare Dis"},{"key":"BFEMMM201708604_CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awt361","volume":"137","author":"M Engelen","year":"2014","unstructured":"Engelen M, Barbier M, Dijkstra IM, Schur R, de Bie RM, Verhamme C, Dijkgraaf MG, Aubourg PA, Wanders RJ, van Geel BM et\u00a0al (2014) X\u2010linked adrenoleukodystrophy in women: a cross\u2010sectional cohort study. Brain 137: 693\u2013706","journal-title":"Brain"},{"key":"BFEMMM201708604_CR20","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1101\/gad.1806309","volume":"23","author":"SP Fancy","year":"2009","unstructured":"Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23: 1571\u20131585","journal-title":"Genes Dev"},{"key":"BFEMMM201708604_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.freeradbiomed.2013.11.014","volume":"67","author":"SA Farr","year":"2014","unstructured":"Farr SA, Ripley JL, Sultana R, Zhang Z, Niehoff ML, Platt TL, Murphy MP, Morley JE, Kumar V, Butterfield DA (2014) Antisense oligonucleotide against GSK\u20103beta in brain of SAMP8 mice improves learning and memory\u00a0and decreases oxidative stress: involvement of transcription factor Nrf2 and implications for Alzheimer disease. Free Radic Biol Med 67: 387\u2013395","journal-title":"Free Radic Biol Med"},{"key":"BFEMMM201708604_CR22","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/hmg\/ddn085","volume":"17","author":"S Fourcade","year":"2008","unstructured":"Fourcade S, Lopez\u2010Erauskin J, Galino J, Duval C, Naudi A, Jove M, Kemp S, Villarroya F, Ferrer I, Pamplona R et\u00a0al (2008) Early oxidative damage underlying neurodegeneration in X\u2010adrenoleukodystrophy. Hum Mol Genet 17: 1762\u20131773","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201708604_CR23","doi-asserted-by":"crossref","first-page":"E211","DOI":"10.1152\/ajpendo.90736.2008","volume":"296","author":"S Fourcade","year":"2009","unstructured":"Fourcade S, Ruiz M, Camps C, Schluter A, Houten SM, Mooyer PA, Pampols T, Dacremont G, Wanders RJ, Giros M et\u00a0al (2009) A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am J Physiol Endocrinol Metab 296: E211\u2013E221","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFEMMM201708604_CR24","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/hmg\/ddq082","volume":"19","author":"S Fourcade","year":"2010","unstructured":"Fourcade S, Ruiz M, Guilera C, Hahnen E, Brichta L, Naudi A, Portero\u2010Otin M, Dacremont G, Cartier N, Wanders R et\u00a0al (2010) Valproic acid induces antioxidant effects in X\u2010linked adrenoleukodystrophy. Hum Mol Genet 19: 2005\u20132014","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201708604_CR25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2015.05.041","volume":"88","author":"S Fourcade","year":"2015","unstructured":"Fourcade S, Ferrer I, Pujol A (2015) Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: a paradigm for axonal degeneration. Free Radic Biol Med 88: 18\u201329","journal-title":"Free Radic Biol Med"},{"key":"BFEMMM201708604_CR26","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","volume":"367","author":"RJ Fox","year":"2012","unstructured":"Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT et\u00a0al (2012) Placebo\u2010controlled phase 3 study of oral BG\u201012 or glatiramer in multiple sclerosis. N Engl J Med 367: 1087\u20131097","journal-title":"N Engl J Med"},{"key":"BFEMMM201708604_CR27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1212\/CPJ.0000000000000238","volume":"6","author":"RJ Fox","year":"2016","unstructured":"Fox RJ, Chan A, Gold R, Phillips JT, Selmaj K, Chang I, Novas M, Rana J, Marantz JL (2016) Characterizing absolute lymphocyte count profiles in dimethyl fumarate\u2010treated patients with MS: patient management considerations. Neurol Clin Pract 6: 220\u2013229","journal-title":"Neurol Clin Pract"},{"key":"BFEMMM201708604_CR28","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1089\/ars.2010.3877","volume":"15","author":"J Galino","year":"2011","unstructured":"Galino J, Ruiz M, Fourcade S, Schluter A, Lopez\u2010Erauskin J, Guilera C, Jove M, Naudi A, Garcia\u2010Arumi E, Andreu AL et\u00a0al (2011) Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of x\u2010adrenoleukodystrophy. Antioxid Redox Signal 15: 2095\u20132107","journal-title":"Antioxid Redox Signal"},{"key":"BFEMMM201708604_CR29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00415-017-8509-9","volume":"264","author":"RJ Gieselbach","year":"2017","unstructured":"Gieselbach RJ, Muller\u2010Hansma AH, Wijburg MT, de Bruin\u2010Weller MS, van Oosten BW, Nieuwkamp DJ, Coenjaerts FE, Wattjes MP, Murk JL (2017) Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases. J Neurol 264: 1155\u20131164","journal-title":"J Neurol"},{"key":"BFEMMM201708604_CR30","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","volume":"367","author":"R Gold","year":"2012","unstructured":"Gold R, Kappos L, Arnold DL, Bar\u2010Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI et\u00a0al (2012) Placebo\u2010controlled phase 3 study of oral BG\u201012 for relapsing multiple sclerosis. N Engl J Med 367: 1098\u20131107","journal-title":"N Engl J Med"},{"key":"BFEMMM201708604_CR31","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1177\/1352458517690617","volume":"23","author":"S Gopal","year":"2017","unstructured":"Gopal S, Mikulskis A, Gold R, Fox RJ, Dawson KT, Amaravadi L (2017) Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed\u2010release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies. Mult Scler 23: 1875\u20131883","journal-title":"Mult Scler"},{"key":"BFEMMM201708604_CR32","doi-asserted-by":"crossref","first-page":"e11903","DOI":"10.7554\/eLife.11903","volume":"5","author":"X Guo","year":"2016","unstructured":"Guo X, Snider WD, Chen B (2016) GSK3beta regulates AKT\u2010induced central nervous system axon regeneration via an eIF2Bepsilon\u2010dependent, mTORC1\u2010independent pathway. Elife 5: e11903","journal-title":"Elife"},{"key":"BFEMMM201708604_CR33","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/hmg\/ddx167","volume":"26","author":"G Hayashi","year":"2017","unstructured":"Hayashi G, Jasoliya M, Sahdeo S, Sacc\u00e0 F, Pane C, Filla A, Marsili A, Puorro G, Lanzillo R, Brescia Morra V et\u00a0al (2017) Dimethyl fumarate mediates Nrf2\u2010dependent mitochondrial biogenesis in mice and humans. Hum Mol Genet 26: 2864\u20132873","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201708604_CR34","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/hmg\/ddn066","volume":"17","author":"S Hein","year":"2008","unstructured":"Hein S, Schonfeld P, Kahlert S, Reiser G (2008) Toxic effects of X\u2010linked adrenoleukodystrophy\u2010associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet 17: 1750\u20131761","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201708604_CR35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/bio.20134853","volume":"2","author":"KM Holmstrom","year":"2013","unstructured":"Holmstrom KM, Baird L, Zhang Y, Hargreaves I, Chalasani A, Land JM, Stanyer L, Yamamoto M, Dinkova\u2010Kostova AT, Abramov AY (2013) Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol Open 2: 761\u2013770","journal-title":"Biol Open"},{"key":"BFEMMM201708604_CR36","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2353\/ajpath.2007.060898","volume":"170","author":"AF Hubbs","year":"2007","unstructured":"Hubbs AF, Benkovic SA, Miller DB, O'Callaghan JP, Battelli L, Schwegler\u2010Berry D, Ma Q (2007) Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2. Am J Pathol 170: 2068\u20132076","journal-title":"Am J Pathol"},{"key":"BFEMMM201708604_CR37","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","volume":"181","author":"NG Innamorato","year":"2008","unstructured":"Innamorato NG, Rojo AI, Garcia\u2010Yague AJ, Yamamoto M, de Ceballos ML, Cuadrado A (2008) The transcription factor Nrf2 Is a therapeutic target against brain inflammation. J Immunol 181: 680\u2013689","journal-title":"J Immunol"},{"key":"BFEMMM201708604_CR38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","volume":"236","author":"K Itoh","year":"1997","unstructured":"Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I et\u00a0al (1997) An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236: 313\u2013322","journal-title":"Biochem Biophys Res Commun"},{"key":"BFEMMM201708604_CR39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2007.01.131","volume":"1144","author":"RJ Jakel","year":"2007","unstructured":"Jakel RJ, Townsend JA, Kraft AD, Johnson JA (2007) Nrf2\u2010mediated protection against 6\u2010hydroxydopamine. Brain Res 1144: 192\u2013201","journal-title":"Brain Res"},{"key":"BFEMMM201708604_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2014.11.047","volume":"286","author":"X Jing","year":"2015","unstructured":"Jing X, Shi H, Zhang C, Ren M, Han M, Wei X, Zhang X, Lou H (2015) Dimethyl fumarate attenuates 6\u2010OHDA\u2010induced neurotoxicity in SH\u2010SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity. Neuroscience 286: 131\u2013140","journal-title":"Neuroscience"},{"key":"BFEMMM201708604_CR41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/toxsci\/kfp274","volume":"114","author":"DA Johnson","year":"2010","unstructured":"Johnson DA, Amirahmadi S, Ward C, Fabry Z, Johnson JA (2010) The absence of the pro\u2010antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol Sci 114: 237\u2013246","journal-title":"Toxicol Sci"},{"key":"BFEMMM201708604_CR42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2015.07.147","volume":"88","author":"DA Johnson","year":"2015","unstructured":"Johnson DA, Johnson JA (2015) Nrf2\u2013a therapeutic target for the treatment of neurodegenerative diseases. Free Radic Biol Med 88: 253\u2013267","journal-title":"Free Radic Biol Med"},{"key":"BFEMMM201708604_CR43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/ars.2011.4491","volume":"18","author":"NA Kaidery","year":"2013","unstructured":"Kaidery NA, Banerjee R, Yang L, Smirnova NA, Hushpulian DM, Liby KT, Williams CR, Yamamoto M, Kensler TW, Ratan RR et\u00a0al (2013) Targeting Nrf2\u2010mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease. Antioxid Redox Signal 18: 139\u2013157","journal-title":"Antioxid Redox Signal"},{"key":"BFEMMM201708604_CR44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.mcn.2008.07.010","volume":"39","author":"K Kanninen","year":"2008","unstructured":"Kanninen K, Malm TM, Jyrkkanen HK, Goldsteins G, Keksa\u2010Goldsteine V, Tanila H, Yamamoto M, Yla\u2010Herttuala S, Levonen AL, Koistinaho J (2008) Nuclear factor erythroid 2\u2010related factor 2 protects against beta amyloid. Mol Cell Neurosci 39: 302\u2013313","journal-title":"Mol Cell Neurosci"},{"key":"BFEMMM201708604_CR45","doi-asserted-by":"crossref","first-page":"16505","DOI":"10.1073\/pnas.0908397106","volume":"106","author":"K Kanninen","year":"2009","unstructured":"Kanninen K, Heikkinen R, Malm T, Rolova T, Kuhmonen S, Leinonen H, Yla\u2010Herttuala S, Tanila H, Levonen AL, Koistinaho M et\u00a0al (2009) Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106: 16505\u201316510","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201708604_CR46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/gim.2016.68","volume":"19","author":"AR Kemper","year":"2017","unstructured":"Kemper AR, Brosco J, Comeau AM, Green NS, Grosse SD, Jones E, Kwon JM, Lam WK, Ojodu J, Prosser LA et\u00a0al (2017) Newborn screening for X\u2010linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. Genet Med 19: 121\u2013126","journal-title":"Genet Med"},{"key":"BFEMMM201708604_CR47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","volume":"12","author":"M Komatsu","year":"2010","unstructured":"Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI et\u00a0al (2010) The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12: 213\u2013223","journal-title":"Nat Cell Biol"},{"key":"BFEMMM201708604_CR48","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1523\/JNEUROSCI.3817-03.2004","volume":"24","author":"AD Kraft","year":"2004","unstructured":"Kraft AD, Johnson DA, Johnson JA (2004) Nuclear factor E2\u2010related factor 2\u2010dependent antioxidant response element activation by tert\u2010butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 24: 1101\u20131112","journal-title":"J Neurosci"},{"key":"BFEMMM201708604_CR49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2015.6549","volume":"25","author":"I Lastres\u2010Becker","year":"2016","unstructured":"Lastres\u2010Becker I, Garcia\u2010Yague AJ, Scannevin RH, Casarejos MJ, Kugler S, Rabano A, Cuadrado A (2016) Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease. Antioxid Redox Signal 25: 61\u201377","journal-title":"Antioxid Redox Signal"},{"key":"BFEMMM201708604_CR50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/ars.2012.4754","volume":"18","author":"A Lau","year":"2013","unstructured":"Lau A, Tian W, Whitman SA, Zhang DD (2013) The predicted molecular weight of Nrf2: it is what it is not. Antioxid Redox Signal 18: 91\u201393","journal-title":"Antioxid Redox Signal"},{"key":"BFEMMM201708604_CR51","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/aws370","volume":"136","author":"N Launay","year":"2013","unstructured":"Launay N, Ruiz M, Fourcade S, Schluter A, Guilera C, Ferrer I, Knecht E, Pujol A (2013) Oxidative stress regulates the ubiquitin\u2010proteasome system and immunoproteasome functioning in a mouse model of X\u2010adrenoleukodystrophy. Brain 136: 891\u2013904","journal-title":"Brain"},{"key":"BFEMMM201708604_CR52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-014-1378-8","volume":"129","author":"N Launay","year":"2015","unstructured":"Launay N, Aguado C, Fourcade S, Ruiz M, Grau L, Riera J, Guilera C, Giros M, Ferrer I, Knecht E et\u00a0al (2015) Autophagy induction halts axonal degeneration in a mouse model of X\u2010adrenoleukodystrophy. Acta Neuropathol 129: 399\u2013415","journal-title":"Acta Neuropathol"},{"key":"BFEMMM201708604_CR53","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-016-1655-9","volume":"133","author":"N Launay","year":"2017","unstructured":"Launay N, Ruiz M, Grau L, Ortega FJ, Ilieva EV, Martinez JJ, Galea E, Ferrer I, Knecht E, Pujol A et\u00a0al (2017) Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X\u2010linked adrenoleukodystrophy. Acta Neuropathol 133: 283\u2013301","journal-title":"Acta Neuropathol"},{"key":"BFEMMM201708604_CR54","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1074\/jbc.M211558200","volume":"278","author":"JM Lee","year":"2003","unstructured":"Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA (2003) Identification of the NF\u2010E2\u2010related factor\u20102\u2010dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 278: 12029\u201312038","journal-title":"J Biol Chem"},{"key":"BFEMMM201708604_CR55","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","volume":"21","author":"H Li","year":"2001","unstructured":"Li H, Li SH, Yu ZX, Shelbourne P, Li XJ (2001) Huntingtin aggregate\u2010associated axonal degeneration is an early pathological event in Huntington's disease mice. J Neurosci 21: 8473\u20138481","journal-title":"J Neurosci"},{"key":"BFEMMM201708604_CR56","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787\u2013795","journal-title":"Nature"},{"key":"BFEMMM201708604_CR57","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","volume":"134","author":"RA Linker","year":"2011","unstructured":"Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S et\u00a0al (2011) Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134: 678\u2013692","journal-title":"Brain"},{"key":"BFEMMM201708604_CR58","first-page":"46","volume":"7","author":"M Llorens\u2010Martin","year":"2014","unstructured":"Llorens\u2010Martin M, Jurado J, Hernandez F, Avila J (2014) GSK\u20103beta, a pivotal kinase in Alzheimer disease. Front Mol Neurosci 7: 46","journal-title":"Front Mol Neurosci"},{"key":"BFEMMM201708604_CR59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.22363","volume":"70","author":"J Lopez\u2010Erauskin","year":"2011","unstructured":"Lopez\u2010Erauskin J, Fourcade S, Galino J, Ruiz M, Schluter A, Naudi A, Jove M, Portero\u2010Otin M, Pamplona R, Ferrer I et\u00a0al (2011) Antioxidants halt axonal degeneration in a mouse model of X\u2010adrenoleukodystrophy. Ann Neurol 70: 84\u201392","journal-title":"Ann Neurol"},{"key":"BFEMMM201708604_CR60","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1093\/hmg\/ddt186","volume":"22","author":"J Lopez\u2010Erauskin","year":"2013","unstructured":"Lopez\u2010Erauskin J, Galino J, Ruiz M, Cuezva JM, Fabregat I, Cacabelos D, Boada J, Martinez J, Ferrer I, Pamplona R et\u00a0al (2013) Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X\u2010linked adrenoleukodystrophy. Hum Mol Genet 22: 3296\u20133305","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201708604_CR61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","volume":"45","author":"S Lovestone","year":"2015","unstructured":"Lovestone S, Boada M, Dubois B, Hull M, Rinne JO, Huppertz HJ, Calero M, Andres MV, Gomez\u2010Carrillo B, Leon T et\u00a0al, (2015) A phase II trial of tideglusib in Alzheimer's disease. J Alzheimers Dis 45: 75\u201388","journal-title":"J Alzheimers Dis"},{"key":"BFEMMM201708604_CR62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.21677","volume":"66","author":"R Mastroeni","year":"2009","unstructured":"Mastroeni R, Bensadoun JC, Charvin D, Aebischer P, Pujol A, Raoul C (2009) Insulin\u2010like growth factor\u20101 and neurotrophin\u20103 gene therapy prevents motor decline in an X\u2010linked adrenoleukodystrophy mouse model. Ann Neurol 66: 117\u2013122","journal-title":"Ann Neurol"},{"key":"BFEMMM201708604_CR63","first-page":"3299","volume":"61","author":"M McMahon","year":"2001","unstructured":"McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, Wolf CR, Cavin C, Hayes JD (2001) The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF\u2010E2 p45\u2010related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 61: 3299\u20133307","journal-title":"Cancer Res"},{"key":"BFEMMM201708604_CR64","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","volume":"118","author":"WP Miller","year":"2011","unstructured":"Miller WP, Rothman SM, Nascene D, Kivisto T, DeFor TE, Ziegler RS, Eisengart J, Leiser K, Raymond G, Lund TC et\u00a0al (2011) Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single\u2010institution cohort report. Blood 118: 1971\u20131978","journal-title":"Blood"},{"key":"BFEMMM201708604_CR65","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.24633","volume":"79","author":"HK Mishra","year":"2016","unstructured":"Mishra HK, Prots I, Havlicek S, Kohl Z, Perez\u2010Branguli F, Boerstler T, Anneser L, Minakaki G, Wend H, Hampl M et\u00a0al (2016) GSK3beta\u2010dependent dysregulation of neurodevelopment in SPG11\u2010patient iPSC model. Ann Neurol 79: 826\u2013840","journal-title":"Ann Neurol"},{"key":"BFEMMM201708604_CR66","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jnc.13837","volume":"139","author":"IE Morales Pantoja","year":"2016","unstructured":"Morales Pantoja IE, Hu CL, Perrone\u2010Bizzozero NI, Zheng J, Bizzozero OA (2016) Nrf2\u2010dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis. J Neurochem 139: 640\u2013650","journal-title":"J Neurochem"},{"key":"BFEMMM201708604_CR67","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/brain\/awt143","volume":"136","author":"L Morato","year":"2013","unstructured":"Morato L, Galino J, Ruiz M, Calingasan NY, Starkov AA, Dumont M, Naudi A, Martinez JJ, Aubourg P, Portero\u2010Otin M et\u00a0al (2013) Pioglitazone halts axonal degeneration in a mouse model of X\u2010linked adrenoleukodystrophy. Brain 136: 2432\u20132443","journal-title":"Brain"},{"key":"BFEMMM201708604_CR68","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/cdd.2015.20","volume":"22","author":"L Morato","year":"2015","unstructured":"Morato L, Ruiz M, Boada J, Calingasan NY, Galino J, Guilera C, Jove M, Naudi A, Ferrer I, Pamplona R et\u00a0al (2015) Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy. Cell Death Differ 22: 1742\u20131753","journal-title":"Cell Death Differ"},{"key":"BFEMMM201708604_CR69","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.410070607","volume":"7","author":"HW Moser","year":"1980","unstructured":"Moser HW, Moser AB, Kawamura N, Murphy J, Suzuki K, Schaumburg H, Kishimoto Y (1980) Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol 7: 542\u2013549","journal-title":"Ann Neurol"},{"key":"BFEMMM201708604_CR70","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/361726a0","volume":"361","author":"J Mosser","year":"1993","unstructured":"Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, Mandel JL, Aubourg P (1993) Putative X\u2010linked adrenoleukodystrophy gene\u00a0shares unexpected homology with ABC transporters. Nature 361: 726\u2013730","journal-title":"Nature"},{"key":"BFEMMM201708604_CR71","doi-asserted-by":"crossref","first-page":"e108655","DOI":"10.1371\/journal.pone.0108655","volume":"9","author":"Z Muneer","year":"2014","unstructured":"Muneer Z, Wiesinger C, Voigtlander T, Werner HB, Berger J, Forss\u2010Petter S (2014) Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1\u2010deficient mice. PLoS One 9: e108655","journal-title":"PLoS One"},{"key":"BFEMMM201708604_CR72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2011.03.027","volume":"51","author":"A Neymotin","year":"2011","unstructured":"Neymotin A, Calingasan NY, Wille E, Naseri N, Petri S, Damiano M, Liby KT, Risingsong R, Sporn M, Beal MF et\u00a0al (2011) Neuroprotective effect of Nrf2\/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 51: 88\u201396","journal-title":"Free Radic Biol Med"},{"key":"BFEMMM201708604_CR73","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2350-11-36","volume":"11","author":"M von Otter","year":"2010","unstructured":"von Otter M, Landgren S, Nilsson S, Celojevic D, Bergstrom P, Hakansson A, Nissbrandt H, Drozdzik M, Bialecka M, Kurzawski M et\u00a0al (2010a) Association of Nrf2\u2010encoding NFE2L2 haplotypes with Parkinson's disease. BMC Med Genet 11: 36","journal-title":"BMC Med Genet"},{"key":"BFEMMM201708604_CR74","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mad.2009.12.007","volume":"131","author":"M von Otter","year":"2010","unstructured":"von Otter M, Landgren S, Nilsson S, Zetterberg M, Celojevic D, Bergstrom P, Minthon L, Bogdanovic N, Andreasen N, Gustafson D et\u00a0al (2010b) Nrf2\u2010encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age\u2010related cataract. Mech Ageing Dev 131: 105\u2013110","journal-title":"Mech Ageing Dev"},{"key":"BFEMMM201708604_CR75","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/15548627.2016.1208889","volume":"12","author":"M Pajares","year":"2016","unstructured":"Pajares M, Jimenez\u2010Moreno N, Garcia\u2010Yague AJ, Escoll M, de Ceballos ML, Van Leuven F, Rabano A, Yamamoto M, Rojo AI, Cuadrado A (2016) Transcription factor NFE2L2\/NRF2 is a regulator of macroautophagy genes. Autophagy 12: 1902\u20131916","journal-title":"Autophagy"},{"key":"BFEMMM201708604_CR76","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00415-017-8594-9","volume":"264","author":"G Pardo","year":"2017","unstructured":"Pardo G, Jones DE (2017) The sequence of disease\u2010modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. J Neurol 264: 2351\u20132374","journal-title":"J Neurol"},{"key":"BFEMMM201708604_CR77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-015-1422-3","volume":"130","author":"B Parodi","year":"2015","unstructured":"Parodi B, Rossi S, Morando S, Cordano C, Bragoni A, Motta C, Usai C, Wipke BT, Scannevin RH, Mancardi GL et\u00a0al (2015) Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue\u00a0synaptic dysregulation in inflamed CNS. Acta Neuropathol 130: 279\u2013295","journal-title":"Acta Neuropathol"},{"key":"BFEMMM201708604_CR78","doi-asserted-by":"crossref","first-page":"e4253","DOI":"10.1371\/journal.pone.0004253","volume":"4","author":"V Paupe","year":"2009","unstructured":"Paupe V, Dassa EP, Goncalves S, Auchere F, Lonn M, Holmgren A, Rustin P (2009) Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS One 4: e4253","journal-title":"PLoS One"},{"key":"BFEMMM201708604_CR79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2016.08.006","volume":"299","author":"H Peng","year":"2016","unstructured":"Peng H, Li H, Sheehy A, Cullen P, Allaire N, Scannevin RH (2016) Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments. J Neuroimmunol 299: 35\u201344","journal-title":"J Neuroimmunol"},{"key":"BFEMMM201708604_CR80","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ymgme.2013.05.009","volume":"109","author":"S Petrillo","year":"2013","unstructured":"Petrillo S, Piemonte F, Pastore A, Tozzi G, Aiello C, Pujol A, Cappa M, Bertini E (2013) Glutathione imbalance in patients with X\u2010linked adrenoleukodystrophy. Mol Genet Metab 109: 366\u2013370","journal-title":"Mol Genet Metab"},{"key":"BFEMMM201708604_CR81","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.jnen.0000190064.28559.a4","volume":"64","author":"JM Powers","year":"2005","unstructured":"Powers JM, Pei Z, Heinzer AK, Deering R, Moser AB, Moser HW, Watkins PA, Smith KD (2005) Adreno\u2010leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol 64: 1067\u20131079","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFEMMM201708604_CR82","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/hmg\/11.5.499","volume":"11","author":"A Pujol","year":"2002","unstructured":"Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL (2002) Late onset neurological phenotype of the X\u2010ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 11: 499\u2013505","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201708604_CR83","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/hmg\/ddh323","volume":"13","author":"A Pujol","year":"2004","unstructured":"Pujol A, Ferrer I, Camps C, Metzger E, Hindelang C, Callizot N, Ruiz M, Pampols T, Giros M, Mandel JL (2004) Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X\u2010adrenoleukodystrophy. Hum Mol Genet 13: 2997\u20133006","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201708604_CR84","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/MCB.01204-10","volume":"31","author":"P Rada","year":"2011","unstructured":"Rada P, Rojo AI, Chowdhry S, McMahon M, Hayes JD, Cuadrado A (2011) SCF\/{beta}\u2010TrCP promotes glycogen synthase kinase 3\u2010dependent degradation of the Nrf2 transcription factor in a Keap1\u2010independent manner. Mol Cell Biol 31: 1121\u20131133","journal-title":"Mol Cell Biol"},{"key":"BFEMMM201708604_CR85","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","volume":"66","author":"CP Ramsey","year":"2007","unstructured":"Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, Hamilton RL, Chu CT, Jordan\u2010Sciutto KL (2007) Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 66: 75\u201385","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFEMMM201708604_CR86","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diabetes.52.3.588","volume":"52","author":"DB Ring","year":"2003","unstructured":"Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T et\u00a0al (2003) Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in\u00a0vitro and in\u00a0vivo. Diabetes 52: 588\u2013595","journal-title":"Diabetes"},{"key":"BFEMMM201708604_CR87","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1096\/fj.08-110866","volume":"22","author":"CW van Roermund","year":"2008","unstructured":"van Roermund CW, Visser WF, Ijlst L, van Cruchten A, Boek M, Kulik W, Waterham HR, Wanders RJ (2008) The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl\u2010CoA esters. FASEB J 22: 4201\u20134208","journal-title":"FASEB J"},{"key":"BFEMMM201708604_CR88","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2007.05124.x","volume":"105","author":"AI Rojo","year":"2008","unstructured":"Rojo AI, Sagarra MR, Cuadrado A (2008) GSK\u20103beta down\u2010regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem 105: 192\u2013202","journal-title":"J Neurochem"},{"key":"BFEMMM201708604_CR89","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/glia.20947","volume":"58","author":"AI Rojo","year":"2010","unstructured":"Rojo AI, Innamorato NG, Martin\u2010Moreno AM, De Ceballos ML, Yamamoto M, Cuadrado A (2010) Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia 58: 588\u2013598","journal-title":"Glia"},{"key":"BFEMMM201708604_CR90","doi-asserted-by":"crossref","first-page":"6861","DOI":"10.1093\/hmg\/ddv384","volume":"24","author":"M Ruiz","year":"2015","unstructured":"Ruiz M, Jove M, Schluter A, Casasnovas C, Villarroya F, Guilera C, Ortega FJ, Naudi A, Pamplona R, Gimeno R et\u00a0al (2015) Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy. Hum Mol Genet 24: 6861\u20136876","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201708604_CR91","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.1074\/jbc.M513737200","volume":"281","author":"M Salazar","year":"2006","unstructured":"Salazar M, Rojo AI, Velasco D, de Sagarra RM, Cuadrado A (2006) Glycogen synthase kinase\u20103beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 281: 14841\u201314851","journal-title":"J Biol Chem"},{"key":"BFEMMM201708604_CR92","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/NEN.0b013e31818b4906","volume":"67","author":"A Sarlette","year":"2008","unstructured":"Sarlette A, Krampfl K, Grothe C, Neuhoff N, Dengler R, Petri S (2008) Nuclear erythroid 2\u2010related factor 2\u2010antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 67: 1055\u20131062","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFEMMM201708604_CR93","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.111.190132","volume":"341","author":"RH Scannevin","year":"2012","unstructured":"Scannevin RH, Chollate S, Jung MY, Shackett M, Patel H, Bista P, Zeng W, Ryan S, Yamamoto M, Lukashev M et\u00a0al (2012) Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid\u2010derived 2)\u2010like 2 pathway. J Pharmacol Exp Ther 341: 274\u2013284","journal-title":"J Pharmacol Exp Ther"},{"key":"BFEMMM201708604_CR94","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2249.2006.03094.x","volume":"145","author":"S Schilling","year":"2006","unstructured":"Schilling S, Goelz S, Linker R, Luehder F, Gold R (2006) Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clin Exp Immunol 145: 101\u2013107","journal-title":"Clin Exp Immunol"},{"key":"BFEMMM201708604_CR95","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/hmg\/ddr536","volume":"21","author":"A Schluter","year":"2012","unstructured":"Schluter A, Espinosa L, Fourcade S, Galino J, Lopez E, Ilieva E, Morato L, Asheuer M, Cook T, McLaren A et\u00a0al (2012) Functional genomic analysis unravels a metabolic\u2010inflammatory interplay in adrenoleukodystrophy. Hum Mol Genet 21: 1062\u20131077","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201708604_CR96","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/ars.2012.4537","volume":"19","author":"Y Shan","year":"2013","unstructured":"Shan Y, Schoenfeld RA, Hayashi G, Napoli E, Akiyama T, Iodi Carstens M, Carstens EE, Pook MA, Cortopassi GA (2013) Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model. Antioxid Redox Signal 19: 1481\u20131493","journal-title":"Antioxid Redox Signal"},{"key":"BFEMMM201708604_CR97","doi-asserted-by":"crossref","first-page":"22925","DOI":"10.1074\/jbc.M414635200","volume":"280","author":"AY Shih","year":"2005","unstructured":"Shih AY, Imbeault S, Barakauskas V, Erb H, Jiang L, Li P, Murphy TH (2005) Induction of the Nrf2\u2010driven antioxidant response confers neuroprotection during mitochondrial stress in\u00a0vivo. J Biol Chem 280: 22925\u201322936","journal-title":"J Biol Chem"},{"key":"BFEMMM201708604_CR98","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1172\/JCI72063","volume":"124","author":"TF da Silva","year":"2014","unstructured":"da Silva TF, Eira J, Lopes AT, Malheiro AR, Sousa V, Luoma A, Avila RL, Wanders RJ, Just WW, Kirschner DA et\u00a0al (2014) Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination. J Clin Invest 124: 2560\u20132570","journal-title":"J Clin Invest"},{"key":"BFEMMM201708604_CR99","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","volume":"49","author":"C Stack","year":"2011","unstructured":"Stack C, Ho D, Wille E, Calingasan NY, Williams C, Liby K, Sporn M, Dumont M, Beal MF (2011) Triterpenoids CDDO\u2010ethyl amide and CDDO\u2010trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. Free Radic Biol Med 49: 147\u2013158","journal-title":"Free Radic Biol Med"},{"key":"BFEMMM201708604_CR100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1352458510364992","volume":"16","author":"E Tallantyre","year":"2010","unstructured":"Tallantyre E, Bo L, Al\u2010Rawashdeh O, Owens T, Polman C, Lowe J, Evangelou N (2010) Clinico\u2010pathological evidence that axonal loss underlies disability in progressive multiple sclerosis. Mult Scler J 16: 406\u2013411","journal-title":"Mult Scler J"},{"key":"BFEMMM201708604_CR101","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","volume":"29","author":"E Tolosa","year":"2014","unstructured":"Tolosa E, Litvan I, Hoglinger GU, Burn D, Lees A, Andres MV, Gomez\u2010Carrillo B, Leon T, Del Ser T, Investigators T (2014) A phase 2 trial of the GSK\u20103 inhibitor tideglusib in progressive supranuclear palsy. Mov Disord 29: 470\u2013478","journal-title":"Mov Disord"},{"key":"BFEMMM201708604_CR102","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jamaneurol.2016.5715","volume":"74","author":"BR Turk","year":"2017","unstructured":"Turk BR, Theisen BE, Nemeth CL, Marx JS, Shi X, Rosen M, Jones RO, Moser AB, Watkins PA, Raymond GV et\u00a0al (2017) Antioxidant capacity and superoxide dismutase activity in adrenoleukodystrophy. JAMA Neurol 74: 519\u2013524","journal-title":"JAMA Neurol"},{"key":"BFEMMM201708604_CR103","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbadis.2003.10.004","volume":"1688","author":"CR Vargas","year":"2004","unstructured":"Vargas CR, Wajner M, Sirtori LR, Goulart L, Chiochetta M, Coelho D, Latini A, Llesuy S, Bello\u2010Klein A, Giugliani R et\u00a0al (2004) Evidence that oxidative stress is increased in patients with X\u2010linked adrenoleukodystrophy. Biochim Biophys Acta 1688: 26\u201332","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM201708604_CR104","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3233\/JAD-161032","volume":"56","author":"Q Wang","year":"2017","unstructured":"Wang Q, Li WX, Dai SX, Guo YC, Han FF, Zheng JJ, Li GH, Huang JF (2017) Meta\u2010analysis of Parkinson's disease and alzheimer's disease revealed commonly impaired pathways and dysregulation of NRF2\u2010dependent genes. J Alzheimers Dis 56: 1525\u20131539","journal-title":"J Alzheimers Dis"},{"key":"BFEMMM201708604_CR105","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1074\/jbc.M112.445445","volume":"288","author":"C Wiesinger","year":"2013","unstructured":"Wiesinger C, Kunze M, Regelsberger G, Forss\u2010Petter S, Berger J (2013) Impaired very long\u2010chain acyl\u2010CoA beta\u2010oxidation in human X\u2010linked\u00a0adrenoleukodystrophy fibroblasts is a direct consequence\u00a0of\u00a0ABCD1 transporter dysfunction. J Biol Chem 288: 19269\u201319279","journal-title":"J Biol Chem"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201708604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201708604","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201708604\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201708604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201708604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:24:02Z","timestamp":1779085442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201708604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":105,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,1]]}},"alternative-id":["BFEMMM201708604"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201708604","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"20 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"EMMM201708604"}}